Clinical Trial Update: Pharmacokinetics of Posaconazole in Children With Chronic Granulomatous Disease (CGD) [Phase 2]

View source ↗

Summary

Phase 2 trial update on the pharmacokinetics of posaconazole in children with Chronic Granulomatous Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatous Disease

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Chronic Granulomatous Disease | Phase 2 | Status: COMPLETED